Suspension of trading

Insiders Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 04:00:00 2025-07-17 pm EDT			5-day change	1st Jan Change
129.46 ^USD	+0.14%		-.--%	+48.43%

Dec. 05	Blueprint Medicines Highlights Long-Term Clinical Benefit of Avapritinib Across Indolent and Advanced Systemic Mastocytosis At 2025 Ash Annual Meeting	CI
Jul. 18	Blueprint Medicines Corporation Announces Termination of Financing Agreement	CI

Insiders

Blueprint Medicines Corporation Announces Directorate and Committee Changes	Jul. 18	CI
Blueprint Medicines Insider Sold Shares Worth $340,033, According to a Recent SEC Filing	Jun. 05	MT
Blueprint Medicines Insider Sold Shares Worth $283,819, According to a Recent SEC Filing	May. 07	MT
Blueprint Medicines Insider Sold Shares Worth $467,266, According to a Recent SEC Filing	Mar. 07	MT
Blueprint Medicines Insider Sold Shares Worth $576,223, According to a Recent SEC Filing	Mar. 07	MT
Blueprint Medicines Insider Sold Shares Worth $576,756, According to a Recent SEC Filing	Mar. 07	MT
Blueprint Medicines Insider Sold Shares Worth $1,434,209, According to a Recent SEC Filing	Mar. 07	MT
Blueprint Medicines Insider Sold Shares Worth $1,660,511, According to a Recent SEC Filing	Jan. 24	MT
Blueprint Medicines Insider Sold Shares Worth $1,869,658, According to a Recent SEC Filing	Nov. 22	MT
Blueprint Medicines Insider Sold Shares Worth $324,500, According to a Recent SEC Filing	24-10-04	MT
Blueprint Medicines Insider Sold Shares Worth $3,905,872, According to a Recent SEC Filing	24-08-07	MT
Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing	24-06-25	MT
Blueprint Medicines Insider Sold Shares Worth $420,520, According to a Recent SEC Filing	24-06-07	MT
Blueprint Medicines Insider Sold Shares Worth $259,263, According to a Recent SEC Filing	24-06-05	MT
Blueprint Medicines Insider Sold Shares Worth $4,136,328, According to a Recent SEC Filing	24-06-04	MT
Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing	24-05-06	MT
Blueprint Medicines Insider Sold Shares Worth $2,188,265, According to a Recent SEC Filing	24-03-22	MT
Blueprint Medicines Insider Sold Shares Worth $500,000, According to a Recent SEC Filing	24-03-01	MT
Blueprint Medicines Insider Sold Shares Worth $395,350, According to a Recent SEC Filing	23-12-13	MT
Blueprint Medicines Insider Sold Shares Worth $375,000, According to a Recent SEC Filing	23-12-11	MT
Blueprint Medicines Insider Sold Shares Worth $352,750, According to a Recent SEC Filing	23-12-04	MT
Blueprint Medicines Insider Sold Shares Worth $1,012,690, According to a Recent SEC Filing	23-11-28	MT
Blueprint Medicines Insider Sold Shares Worth $601,980, According to a Recent SEC Filing	23-11-03	MT
Blueprint Medicines Insider Sold Shares Worth $181,138, According to a Recent SEC Filing	23-10-05	MT
Blueprint Medicines Insider Sold Shares Worth $1,244,030, According to a Recent SEC Filing	23-09-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Biotechnology & Medical Research

Insiders

Filters